Cancer Diagnosis and Imaging-Guided Photothermal Therapy Using a Dual-Modality Nanoparticle
Source abstract
Abstract
To improve patient outcome and decrease overall health-care costs, highly sensitive and precise detection of a tumor is required for its accurate diagnosis and efficient therapy; however, this remains a challenge when using conventional single mode imaging. Here, we successfully designed a near-infrared (NIR)-response photothermal therapy (PTT) platform (Au@MSNs-ICG) for the location, diagnosis, and NIR/computer tomography (CT) bimodal imaging-guided PTT of tumor tissues, using gold (Au) nanospheres coated with indocyanine green (ICG)-loaded mesoporous silica nanoparticles (MSNs), which would have high sensitivity and precision. The nanoparticles (NPs) exhibited good monodispersity, fluorescence stability, biocompatibility, and NIR/CT signaling and had a preferable temperature response under NIR laser irradiation in vitro or in vivo. Using a combination of NIR/CT imaging and PTT treatment, the tumor could be accurately positioned and thoroughly eradicated in vivo by Au@MSNs-ICG injection. Hence, the multifunctional NPs could play an important role in facilitating the accurate treatment of tumors in future clinical applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China
Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, No. 253, Gongye Avenue, Guangzhou 510280, China
Beijing Key Laboratory of Molecular Imaging, Zhongguancun East Road #95, Haidian District, Beijing 100190, China
Funding
Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China
References (55)
Show source-provided references
1. 10.1093/jnci/djv30910.1093/jnci/djv309 ↗
2. Stewart, B. W.; Wild, C. P., Eds.World cancer report 2014;World Health Organization:Geneva, Switzerland, 2015; Chapter 1, pp25–106.
3. 10.1016/S1470-2045(15)00218-110.1016/S1470-2045(15)00218-1 ↗
4. 10.1148/radiol.201514210110.1148/radiol.2015142101 ↗
5. 10.1148/radiol.201514298610.1148/radiol.2015142986 ↗
6. 10.1097/MD.000000000000115710.1097/MD.0000000000001157 ↗
7. 10.1148/radiol.232303089610.1148/radiol.2323030896 ↗
8. 10.1038/nrclinonc.2014.19110.1038/nrclinonc.2014.191 ↗
9. 10.1056/NEJMc120663010.1056/NEJMc1206630 ↗
10. 10.1016/S1470-2045(14)71104-010.1016/S1470-2045(14)71104-0 ↗
11. 10.1016/S1470-2045(13)70555-210.1016/S1470-2045(13)70555-2 ↗
12. 10.4254/wjh.v7.i5.78710.4254/wjh.v7.i5.787 ↗
13. 10.1016/S2213-2600(13)70159-010.1016/S2213-2600(13)70159-0 ↗
14. 10.1097/SLA.0b013e31828ee17c10.1097/SLA.0b013e31828ee17c ↗
15. 10.1002/smll.20150210210.1002/smll.201502102 ↗
16. 10.1021/acsami.5b0203710.1021/acsami.5b02037 ↗
17. 10.2147/IJN.S6017110.2147/IJN.S60171 ↗
18. 10.7150/thno.989910.7150/thno.9899 ↗
19. 10.1021/acsami.5b0072710.1021/acsami.5b00727 ↗
20. 10.1039/C5NR02269J10.1039/C5NR02269J ↗
21. 10.1016/j.biomaterials.2016.05.02710.1016/j.biomaterials.2016.05.027 ↗
22. 10.1007/s10549-013-2802-910.1007/s10549-013-2802-9 ↗
23. 10.1038/nrc356610.1038/nrc3566 ↗
24. 10.1073/pnas.140082111110.1073/pnas.1400821111 ↗
25. 10.1002/jso.2194310.1002/jso.21943 ↗
26. 10.1038/srep2195910.1038/srep21959 ↗
27. 10.1021/cr200358s10.1021/cr200358s ↗
28. 10.1002/adhm.20120003210.1002/adhm.201200032 ↗
29. 10.1021/ar300150c10.1021/ar300150c ↗
30. 10.1002/adma.20110328910.1002/adma.201103289 ↗
31. 10.1038/nmat157110.1038/nmat1571 ↗
32. 10.1021/ar100063310.1021/ar1000633 ↗
33. 10.1007/s00234-013-1298-710.1007/s00234-013-1298-7 ↗
34. 10.7150/thno.1167910.7150/thno.11679 ↗
35. 10.1016/j.talanta.2012.05.06910.1016/j.talanta.2012.05.069 ↗
36. 10.1039/C4CS00011K10.1039/C4CS00011K ↗
37. 10.1016/j.jhep.2010.07.04710.1016/j.jhep.2010.07.047 ↗
38. 10.1002/cmdc.20120023310.1002/cmdc.201200233 ↗
39. 10.1002/asia.20120103310.1002/asia.201201033 ↗
40. 10.1111/cas.1255310.1111/cas.12553 ↗
41. 10.1016/j.pdpdt.2014.02.00110.1016/j.pdpdt.2014.02.001 ↗
42. 10.1021/bi500021j10.1021/bi500021j ↗
43. 10.1039/C5DT01286D10.1039/C5DT01286D ↗
44. 10.1021/ja200120k10.1021/ja200120k ↗
45. 10.2147/IJN.S8294010.2147/IJN.S82940 ↗
46. 10.1039/C5NR02521D10.1039/C5NR02521D ↗
47. 10.1021/acsnano.5b0274910.1021/acsnano.5b02749 ↗
48. 10.1021/acsami.5b0435910.1021/acsami.5b04359 ↗
49. 10.1364/OE.19.01703010.1364/OE.19.017030 ↗
50. 10.1021/nn504764710.1021/nn5047647 ↗
51. 10.1016/j.biomaterials.2011.10.03910.1016/j.biomaterials.2011.10.039 ↗
52. 10.1039/B514191E10.1039/B514191E ↗
53. 10.1002/anie.20140303610.1002/anie.201403036 ↗
54. 10.1002/adma.20130008110.1002/adma.201300081 ↗
55. 10.1021/nn506137n10.1021/nn506137n ↗